Extract from the Register of European Patents

EP About this file: EP3110403

EP3110403 - TASTE MASKING DRUG FORMULATIONS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.09.2020
Database last updated on 30.03.2026
FormerThe patent has been granted
Status updated on  04.10.2019
FormerGrant of patent is intended
Status updated on  14.05.2019
FormerExamination is in progress
Status updated on  27.07.2018
FormerRequest for examination was made
Status updated on  02.12.2016
FormerThe international publication has been made
Status updated on  30.11.2016
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Adare Pharmaceuticals USA, Inc.
1200 Lenox Drive, Suite 100
Lawrenceville, NJ 08648 / US
[2020/36]
Former [2019/43]For all designated states
Orbis Biosciences, Inc.
8006 Reeder Street
Lenexa, KS 66214 / US
Former [2017/01]For all designated states
Orbis Biosciences, Inc.
2002 W. 39th Avenue
Kansas City, KS 66103 / US
Inventor(s)01 / BERKLAND, Cory
1117 E. 1264 Road
Lawrence, KS 66047 / US
02 / SINGH, Milind
2509 Livingston Ct
Apex, North Carolina 27502 / US
 [2017/01]
Representative(s)Cooley (UK) LLP
22 Bishopsgate
London EC2N 4BQ / GB
[N/P]
Former [2019/45]Potter Clarkson
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Former [2017/01]Potter Clarkson LLP
The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
Application number, filing date15754648.225.02.2015
[2017/01]
WO2015US17485
Priority number, dateUS201461944152P25.02.2014         Original published format: US 201461944152 P
[2017/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015130760
Date:03.09.2015
Language:EN
[2015/35]
Type: A1 Application with search report 
No.:EP3110403
Date:04.01.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 03.09.2015 takes the place of the publication of the European patent application.
[2017/01]
Type: B1 Patent specification 
No.:EP3110403
Date:06.11.2019
Language:EN
[2019/45]
Search report(s)International search report - published on:US03.09.2015
(Supplementary) European search report - dispatched on:EP06.09.2017
ClassificationIPC:A61K9/50, A61K9/00, A61K47/10, A61K31/426, A61K31/573
[2019/19]
CPC:
A61K9/5026 (EP,US); A61K31/426 (US); A61K31/573 (US);
A61K47/10 (EP,US); A61K9/0053 (EP,US); A61K9/5015 (EP,US);
A61K9/5063 (EP,US); A61K9/5089 (EP,US) (-)
Former IPC [2017/40]A61K9/14, A61K9/50, A61K9/00, A61K47/10
Former IPC [2017/01]A61K9/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/01]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:GESCHMACKSMASKIERENDE ARZNEIMITTELFORMULIERUNGEN[2017/01]
English:TASTE MASKING DRUG FORMULATIONS[2017/01]
French:PRÉPARATIONS PHARMACEUTIQUES DE MASQUAGE DU GOÛT[2017/01]
Entry into regional phase14.09.2016National basic fee paid 
14.09.2016Search fee paid 
14.09.2016Designation fee(s) paid 
14.09.2016Examination fee paid 
Examination procedure14.09.2016Examination requested  [2017/01]
14.09.2016Date on which the examining division has become responsible
21.03.2018Amendment by applicant (claims and/or description)
25.07.2018Despatch of a communication from the examining division (Time limit: M06)
21.12.2018Reply to a communication from the examining division
15.05.2019Communication of intention to grant the patent
25.09.2019Fee for grant paid
25.09.2019Fee for publishing/printing paid
25.09.2019Receipt of the translation of the claim(s)
Opposition(s)07.08.2020No opposition filed within time limit [2020/42]
Fees paidRenewal fee
27.02.2017Renewal fee patent year 03
15.02.2018Renewal fee patent year 04
26.02.2019Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU25.02.2015
AL06.11.2019
AT06.11.2019
CY06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
IT06.11.2019
LT06.11.2019
LV06.11.2019
MC06.11.2019
MK06.11.2019
MT06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
SI06.11.2019
SK06.11.2019
SM06.11.2019
TR06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
LU25.02.2020
BE29.02.2020
IS06.03.2020
PT06.03.2020
[2022/32]
Former [2022/27]HU25.02.2015
AL06.11.2019
AT06.11.2019
CY06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
IT06.11.2019
LT06.11.2019
LV06.11.2019
MC06.11.2019
MT06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
SI06.11.2019
SK06.11.2019
SM06.11.2019
TR06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
LU25.02.2020
BE29.02.2020
IS06.03.2020
PT06.03.2020
Former [2021/10]AL06.11.2019
AT06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
IT06.11.2019
LT06.11.2019
LV06.11.2019
MC06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
SI06.11.2019
SK06.11.2019
SM06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
LU25.02.2020
BE29.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/50]AL06.11.2019
AT06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
MC06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
SI06.11.2019
SK06.11.2019
SM06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
LU25.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/48]AL06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
SK06.11.2019
SM06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
LU25.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/37]AL06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
SK06.11.2019
SM06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/36]AL06.11.2019
CZ06.11.2019
DK06.11.2019
EE06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/35]AL06.11.2019
CZ06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RO06.11.2019
RS06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/34]AL06.11.2019
ES06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RS06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/32]AL06.11.2019
FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RS06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/25]FI06.11.2019
HR06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
RS06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/24]FI06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
IS06.03.2020
PT06.03.2020
Former [2020/23]FI06.11.2019
LT06.11.2019
LV06.11.2019
NL06.11.2019
PL06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
GR07.02.2020
PT06.03.2020
Former [2020/22]FI06.11.2019
LT06.11.2019
SE06.11.2019
BG06.02.2020
NO06.02.2020
PT06.03.2020
Former [2020/21]NO06.02.2020
Documents cited:Search[XY] US2006141053  (MENJOGE ANUPA R et al.) [X] 1-5,7-9,11-14 * paragraphs [0035] - [0037] - [0045] , [0056]; example 3; claim 1 *[Y] 6,10
 [XY] WO0152848  (EURAND AMERICA INC et al.) [X] 1-5,7-9,11-14 * examples 1-3; claims 1,2 *[Y] 6,10
 [Y] US2008020018  (MOODLEY JOEY et al.) [Y] 6,10 * example 1 *
 [Y]   "Masking the taste of fast-disintegrating tablets", INNOVATIONS IN PHARMACEUTICAL TECHNO, XX, XX, vol. 14, no. 4, 1 January 2004 (2004-01-01), pages 109 - 111, XP008050337 [Y] 6,10 * page110, right column *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.